Patent 8003674 was granted and assigned to Oregon Health & Science University on August, 2011 by the United States Patent and Trademark Office.
Disclosed herein are compounds, compositions and methods for treating or ameliorating flavivirus infections. This is particularly important because the present disclosure provides methods for treating flavivirus infections for which there is no effective vaccine.